NB
Nabriva Therapeutics plc
NBRVF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $323.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
78 /100
Growing Rev. growth 66.35%
Book val. growth 56.95%
EPS growth N/A
Profitability
6 /100
Weak Gross margin 19.87%
FCF margin 103.52%
Net margin 160.33%
Quality
20 /100
Poor ROIC 634.43%
Asset turnover 1.12x
ROA 180.03%
Debt
51 /100
Moderate Debt/Equity 1.59x
Net debt/EBITDA 0.13x
Current ratio 1.13x
Stability
35 /100
Moderate Beta -0.68x
Profitable years 0
Rev. volatility 258.14%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NBRVF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
H. Michael Hogan
Employees
39
Headquarters
Dublin
Evenimente viitoare
13 NOV.
Earnings
Upcoming earnings report